Target Information
General Information of This Target (ID: PATR0UFYDR)
| Target Name | Dihydrofolate reductase (DHFR) |
|||||
|---|---|---|---|---|---|---|
| Gene Name | DHFR |
|||||
| Gene ID | ||||||
| Sequence |
MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFS
IPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSS VYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKF EVYEKND Click to Show/Hide
|
|||||
| Family | the dihydrofolate reductase family |
|||||
| Function |
Key enzyme in folate metabolism. Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis. Binds its own mRNA and that of DHFR2.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Full List of The ADC Related to This Target
Investigative
| ADC Name | Antibody | Antigen | Payload | Linker | ADC Info |
|---|---|---|---|---|---|
|
B5-MTX
[1]
|
Anti-DLA-DR mAb B5 |
Dog leukocyte antigen DR (DLA-DR) |
Methotrexate |
Undisclosed |
Investigative(Terminated)
| ADC Name | Antibody | Antigen | Payload | Linker | ADC Info |
|---|---|---|---|---|---|
|
Monoclonal antibody 791T-36-methotrexate conjugate
[2]
|
791T-36 |
Complement decay-accelerating factor (CD55) |
Methotrexate |
Undisclosed |
Phase 2
| ADC Name | Antibody | Antigen | Payload | Linker | ADC Info |
|---|---|---|---|---|---|
|
IGF-MTX
[3]
|
Anti-IGF1R mAb |
Insulin-like growth factor 1 receptor (IGF1R) |
Methotrexate |
Undisclosed |
References
